Mendel is a hybrid intelligent engine (human/AI) that can collect patient's medical records and combine it with the genetic profile of her/his cancer to find matching : personalized meds that are still in the trial phase and/or oncologists with a track record matching the patient's case for a second opinion. Mendel's business model is free for patients, including the 56% of cancer patients outside US/Europe.
MENDEL NEWSVIEW ALL
YOU MIGHT ALSO BE INTERESTED IN
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.